<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01087086</url>
  </required_header>
  <id_info>
    <org_study_id>RESMENA-S</org_study_id>
    <nct_id>NCT01087086</nct_id>
  </id_info>
  <brief_title>Reduction of the Metabolic Syndrome in Navarra-Spain</brief_title>
  <acronym>RESMENA-S</acronym>
  <official_title>Reduction of the Metabolic Syndrome in Navarra-Spain (RESMENA-S) Through an Innovative Multidisciplinary Strategy Based on the Crononutrition and Dietary Training Concepts, in Addition to Both Dietary and Psychological Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinica Universidad de Navarra, Universidad de Navarra</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital of Navarra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinica Universidad de Navarra, Universidad de Navarra</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a dietary pattern based on crononutrition
      and dietary training, together with dietary and psychological control, can reduce the body
      weight, improve the oxidative and inflammatory state in subjects with diagnosed metabolic
      syndrome features and can reduce the prevalence of the Metabolic syndrome in the population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The dietary pattern that characterizes the present nutritional intervention study is based on
      personalized diet, by elaborating tailoring-diets for each subject regarding his energetic
      needs and assuring a high adherence to the Mediterranean Diet. Moreover, the diet to be
      performed will be a hyperproteic diet to guarantee a satiety effect and a lower recovery of
      the lost weight, in accordance with the results derived from the main European study about
      nutrition (DIOGENES). The glycemic index/load will be also controlled in the study diet. The
      increase of the antioxidant capacity of the diet will be increased by the intake of fruits,
      walnuts and virgin olive oil among other antioxidant containing foods.

      The present initiative, based on the traditional diet, aims to integrate the main results
      obtained from diverse observational epidemiological studies and interventional studies in the
      dietary pattern of the present study. At the same time, the study will apply the concept of
      crononutrition by selecting and distributing the foods thorough the day according the
      physiological needs of each individual.

      In addition to the quantitative and qualitative composition of the diet, the study will take
      into account other important factors such as the behavior habits regarding the food, the
      frequency of consumption, the size of the eating portions, the distribution of the portions
      along the day, the feeling of fullness, the eating speed and so on. The aforementioned
      factors have recently been shown to be related to the gain of weight.

      Other non dietary factors, such as smoking habits, sedentary life, socio-economic level, will
      be also controlled in the present study. Moreover, the project will integrate the dietary
      support together with psychological support due to the fact that the state of mind has been
      shown to be associated with the MS in some scientific publications.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body fat</measure>
    <time_frame>One year</time_frame>
    <description>Through this specific nutritional intervention program we will try to reduce the metabolic syndrome features such as waist circumference, body weight and adiposity.
To evaluate the body composition, bioimpedance, DEXA and anthropometry methodology will be used at the beginning and after two months of intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>One year</time_frame>
    <description>To evaluate lipid improvements the following measurements will be taking into account:
Free fatty acids
Total cholesterol
HDL-cholesterol
LDL-cholesterol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose Profile</measure>
    <time_frame>One year</time_frame>
    <description>To evaluate glucose improvements the following measurements will be taking into account:
Glucose
Insulin
HOMA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammation state</measure>
    <time_frame>One year</time_frame>
    <description>As secondary outcome some inflammatory markers will be analyzed:
CRP
IL-6
TNF-alpha
IL-18
PAI-1
Homocystein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress</measure>
    <time_frame>One year</time_frame>
    <description>As secondary outcome some oxidative stress markers will be analyzed:
MDA
LDL-OX
Total antioxidant capacity (TAC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological tests</measure>
    <time_frame>January 2010-November 2011</time_frame>
    <description>Beck Depression Inventory
Stai Trait Anxiety Inventory
Mood thermometer visual analogue scale
Anxiety thermometer visual analogue scale
NEO personality inventory-revised test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral neurotransmitters</measure>
    <time_frame>March-April 2013</time_frame>
    <description>Dopamine
Dopac
Serotonin
5-Hydroxyindoleacetic acid
Noradrenaline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epigenetics</measure>
    <time_frame>April 2012-July 2014</time_frame>
    <description>DNA methylation
microRNAs expression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatty Liver biomarkers / Non invasive liver scoring system.</measure>
    <time_frame>May 2016- January 2017</time_frame>
    <description>Measurements in fatty liver biomarkers:
Serum transaminases (AST &amp; ALT (U/L)), GGT (U/L) and CK18 (U/L) concentrations will be measured in a fasting state at the beginning, at 2 months and at the end of the intervention.
- A specificif Fatty Liver Index was calculated at the begining, at 2 months and at the end of the intervention.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">109</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Crononutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary pattern:
Personalized diet
Caloric restriction (-30% Total energy intake)
High adherence to the Mediterranean Diet
Macronutrient distribution (30% Protein, 40% Carbohydrates and 30% Fat)
Low glycemic index/load
Increased antioxidant capacity of the diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>American Heart Association</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dietary pattern:
Personalized diet
Caloric diet (-30% Total energy intake)
Macronutrients distribution according to the American Heart Association (AHA) guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Crononutrition</intervention_name>
    <description>After the recruitment and selection of the study participants, the study will consists of a 2-month nutritional intervention (Crononutrition versus AHA) followed by second 6-month period (&quot;autonomy phase&quot;) in which the subjects of the study will continue with their ruled dietary patterns, but without any dietary or psychological support.</description>
    <arm_group_label>Crononutrition</arm_group_label>
    <other_name>RYTHMONUTRITION</other_name>
    <other_name>METABOLIC SYNDROME</other_name>
    <other_name>OBESITY</other_name>
    <other_name>DIABETES</other_name>
    <other_name>CARDIOVASCULAR DISEASE</other_name>
    <other_name>RESMENA-S</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>American Heart Association</intervention_name>
    <description>After the recruitment and selection of the study participants, the study will consists of a 2-month nutritional intervention (Crononutrition versus AHA) followed by second 6-month period (&quot;autonomy phase&quot;) in which the subjects of the study will continue with their ruled dietary patterns, but without any dietary or psychological support.</description>
    <arm_group_label>American Heart Association</arm_group_label>
    <other_name>RESMENA-A</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  35-70 years old

          -  Both sexes: Male and Female

          -  Metabolic Syndrome according to the IDF(2005)criteria:

        Waist circumference cutoffs (male ≥94 cm or female ≥80 cm) plus any two of the following
        four factors:

          1. Fasting glucose ≥5.55 mmol/L or use of antidiabetic medication

          2. Systolic BP ≥130 mm Hg, diastolic BP ≥85 mm Hg, or use of antihypertensive medication

          3. Fasting triglycerides ≥1.7 mm/L; and HDL-C &lt;1.0 mm/L in men and &lt;1.3 mm/L in women or
             specific treatment for this lipid abnormality

        Exclusion Criteria:

          -  Recent follow-up of diets designed for weight loss

          -  Unstable weight in the past 3 months

          -  Alcoholic and drug dependence

          -  Hormonal treatment

          -  No stable pharmacological treatment

          -  Eating-disordered behaviors

          -  Severe physical or mental disability

          -  Pregnancy

          -  Terminal disease

          -  Institutionalization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>María Ángeles MA Zulet, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José Alfredo JA Martínez, PhD, RN</last_name>
    <role>Study Director</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Itziar I Abete, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lluis L Forga, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Blanca Esther BE Martínez de Morentin, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Santiago S Navas-Carretero, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rocío R de la Iglesia, M.Sc</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patricia P López Legarrea, M.Sc</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabel I Bondia-Pons, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aurora A Perez Cornago, M.Sc</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José Luiz JL Marques-Rocha, M.Sc</last_name>
    <role>Study Chair</role>
    <affiliation>Universidade Federal de Viçosa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcos M García-Lacarte, M.Sc</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Irene I Cantero, M.Sc</last_name>
    <role>Study Chair</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.unav.es/caft/</url>
    <description>Department of Nutrition, Food Science, Physiology and Toxicology</description>
  </link>
  <reference>
    <citation>Hermsdorff HH, Zulet MÁ, Abete I, Martínez JA. Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine. 2009 Dec;36(3):445-51. doi: 10.1007/s12020-009-9248-1.</citation>
    <PMID>19816812</PMID>
  </reference>
  <reference>
    <citation>Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition. 2010 May;26(5):534-41. doi: 10.1016/j.nut.2009.06.017. Epub 2009 Sep 26.</citation>
    <PMID>19783122</PMID>
  </reference>
  <reference>
    <citation>Pérez-Matute P, Zulet MA, Martínez JA. Reactive species and diabetes: counteracting oxidative stress to improve health. Curr Opin Pharmacol. 2009 Dec;9(6):771-9. doi: 10.1016/j.coph.2009.08.005. Epub 2009 Sep 18. Review.</citation>
    <PMID>19766058</PMID>
  </reference>
  <reference>
    <citation>Toledo E, de A Carmona-Torre F, Alonso A, Puchau B, Zulet MA, Martinez JA, Martinez-Gonzalez MA. Hypothesis-oriented food patterns and incidence of hypertension: 6-year follow-up of the SUN (Seguimiento Universidad de Navarra) prospective cohort. Public Health Nutr. 2010 Mar;13(3):338-49. doi: 10.1017/S1368980009991066. Epub 2009 Aug 6.</citation>
    <PMID>19656442</PMID>
  </reference>
  <reference>
    <citation>Sotos-Prieto M, Zulet MA, Corella D. [Scientific evidence of the mediterranean diet effects in determining intermediate and final cardiovascular disease phenotypes]. Med Clin (Barc). 2010 Jan 23;134(1):22-9. doi: 10.1016/j.medcli.2009.01.033. Epub 2009 May 19. Review. Spanish.</citation>
    <PMID>19457510</PMID>
  </reference>
  <reference>
    <citation>Puchau B, Zulet MA, González de Echávarri A, Navarro-Blasco I, Martínez JA. Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults. Eur J Clin Nutr. 2009 Jul;63(7):858-64. doi: 10.1038/ejcn.2008.48. Epub 2008 Nov 5.</citation>
    <PMID>18985060</PMID>
  </reference>
  <reference>
    <citation>Zulet MA, Puchau B, Navarro C, Martí A, Martínez JA. [Inflammatory biomarkers: the link between obesity and associated pathologies]. Nutr Hosp. 2007 Sep-Oct;22(5):511-27. Review. Spanish.</citation>
    <PMID>17970534</PMID>
  </reference>
  <reference>
    <citation>Abete I, Parra MD, Zulet MA, Martínez JA. Different dietary strategies for weight loss in obesity: role of energy and macronutrient content. Nutr Res Rev. 2006 Jun;19(1):5-17. doi: 10.1079/NRR2006112.</citation>
    <PMID>19079872</PMID>
  </reference>
  <reference>
    <citation>Martínez MA, Puig JG, Mora M, Aragón R, O'Dogherty P, Antón JL, Sánchez-Villares T, Rubio JM, Rosado J, Torres R, Marcos J, Pallardo LF, Banegas JR; MAPA (Monitorización Ambulatoria de la Presión Arterial) Working Group. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study. Metabolism. 2008 Sep;57(9):1232-40. doi: 10.1016/j.metabol.2008.04.017.</citation>
    <PMID>18702949</PMID>
  </reference>
  <reference>
    <citation>Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Fernández-Labandera C, Cabrera M, Sáinz JC, Fernández-Meseguer A, Banegas JR, Ruilope LM, Valdivielso P, Román-García J; Ibermutuamur Cardiovascular Risk Assessment (ICARIA) Study Group. Occupation-related differences in the prevalence of metabolic syndrome. Diabetes Care. 2008 Sep;31(9):1884-5. doi: 10.2337/dc08-0431. Epub 2008 Jun 20.</citation>
    <PMID>18753667</PMID>
  </reference>
  <reference>
    <citation>Babio N, Bulló M, Basora J, Martínez-González MA, Fernández-Ballart J, Márquez-Sandoval F, Molina C, Salas-Salvadó J; Nureta-PREDIMED Investigators. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):563-70. doi: 10.1016/j.numecd.2008.10.007. Epub 2009 Jan 26.</citation>
    <PMID>19176282</PMID>
  </reference>
  <reference>
    <citation>Abete I, Parra D, Martinez JA. Legume-, fish-, or high-protein-based hypocaloric diets: effects on weight loss and mitochondrial oxidation in obese men. J Med Food. 2009 Feb;12(1):100-8. doi: 10.1089/jmf.2007.0700.</citation>
    <PMID>19298202</PMID>
  </reference>
  <reference>
    <citation>Goyenechea E, Parra D, Crujeiras AB, Abete I, Martínez JA. A nutrigenomic inflammation-related PBMC-based approach to predict the weight-loss regain in obese subjects. Ann Nutr Metab. 2009;54(1):43-51. doi: 10.1159/000205319. Epub 2009 Feb 27.</citation>
    <PMID>19246894</PMID>
  </reference>
  <reference>
    <citation>Abete I, Parra D, Martinez JA. Energy-restricted diets based on a distinct food selection affecting the glycemic index induce different weight loss and oxidative response. Clin Nutr. 2008 Aug;27(4):545-51. doi: 10.1016/j.clnu.2008.01.005. Epub 2008 Mar 4.</citation>
    <PMID>18308431</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2010</study_first_submitted>
  <study_first_submitted_qc>March 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2010</study_first_posted>
  <last_update_submitted>May 11, 2016</last_update_submitted>
  <last_update_submitted_qc>May 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Proinflammatory state</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Dyslipidemia</keyword>
  <keyword>Mediterranean diet</keyword>
  <keyword>Glycemic index</keyword>
  <keyword>Hypocaloric diet</keyword>
  <keyword>Hyperproteic diet</keyword>
  <keyword>Macronutrient distribution</keyword>
  <keyword>Antioxidant capacity of the diet</keyword>
  <keyword>Crononutrition</keyword>
  <keyword>Dietary and psychological support</keyword>
  <keyword>Waist circumference</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

